WEST PHARMACEUTICAL SERVICES, INC. Increase (Decrease) in Inventories
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Increase (Decrease) in Inventories of $62.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in inventories for fiscal 2025 was $62.80M.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in inventories for fiscal 2024 was -$42.00M, a 411.11% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in inventories for fiscal 2023 was $13.50M, a 72.89% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in inventories for fiscal 2022 was $49.80M, a 42.43% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|
| 2025-12-31 | $62.80M 10-K · filed 2026-02-17 | |
| 2024-12-31 | -$42.00M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $13.50M 10-K · filed 2026-02-17 | |
| 2022-12-31 | $49.80M 10-K · filed 2025-02-18 | |
| 2021-12-31 | $86.50M 10-K · filed 2024-02-20 | |
| 2020-12-31 | $73.70M 10-K · filed 2023-02-21 | |
| 2019-12-31 | $18.60M 10-K · filed 2022-02-22 | |
| 2018-12-31 | $7.00M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $3.60M 10-K · filed 2020-02-24 | |
| 2016-12-31 | $21.20M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $11.40M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $16.20M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $13.90M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $8.90M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $9.30M 10-K · filed 2014-02-27 | |
| 2010-12-31 | $20.70M 10-K · filed 2013-02-27 | -$20.70M 10-K · filed 2011-02-28 |
| 2009-12-31 | $6.40M 10-K/A · filed 2012-03-01 | -$6.40M 10-K · filed 2011-02-28 |
| 2008-12-31 | -$13.40M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |